MoonLake Immunotherapeutics (MLTX) Financials

$45.06

south_east
-$2.05 (-4.35%)
Day's range
$44.87
Day's range
$48.53

MLTX Income statement / Annual

Last year (2023), MoonLake Immunotherapeutics's total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, MoonLake Immunotherapeutics's net income was -$36.01 M. See MoonLake Immunotherapeutics,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $13,158.00 $12,358.00 $4,971.00 $0.00
Gross Profit -$13,158.00 -$12,358.00 -$4,971.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $31.79 M $42.05 M $35.52 M $0.00
General & Administrative Expenses $22.32 M $23.01 M $21.66 M $0.00
Selling & Marketing Expenses $0.00 $0.00 $18.03 M $0.00
Selling, General & Administrative Expenses $22.32 M $23.01 M $18.05 M $105,755.00
Other Expenses $0.00 $591,732.00 $0.00 $0.00
Operating Expenses $54.12 M $65.06 M $53.57 M $105,755.00
Cost And Expenses $54.12 M $65.06 M $53.58 M $105,755.00
Interest Income $0.00 $0.00 $0.00 $14,917.00
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $13,158.00 $12,358.00 $4,971.00 $206,297.00
EBITDA -$54.11 M -$65.05 M -$53.63 M -$90,838.00
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net $10.14 M $591,732.00 $10.65 M $14,922.00
Income Before Tax -$43.98 M -$64.47 M -$53.64 M -$90,838.00
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $94,388.00 $36,366.00 $4,755.00 -$206,297.00
Net Income -$36.01 M -$64.51 M -$53.64 M -$90,838.00
Net Income Ratio 0 0 0 0
EPS -0.73 -2.2 -6.84 -0.0061
EPS Diluted -0.73 -2.2 -6.84 -0.0061
Weighted Average Shares Out $49.12 M $29.36 M $7.84 M $14.81 M
Weighted Average Shares Out Diluted $49.12 M $29.36 M $7.84 M $14.81 M
Link